| Market Cap | ₹66,663Cr |
| ROE | 17.69% |
| P/E Ratio(TTM) | 27.52 |
| EPS(TTM) | 202.60 |
| P/B Ratio | 5.00 |
| Dividend Yield | 0.81% |
| Industry P/E | 32.50 |
| Book Value | 1116.21 |
| Debt to Equity | 0.18 |
| Face Value | 2 |
| Managing Director | Dr. Vikas Gupta |
| Founded | 1973 |
| NSE Symbol | ALKEM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 38.39 | ||
| Cipla | NA (0.00%) | 24.09 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 19.57 | ||
| Lupin | NA (0.00%) | 22.63 |